Pembrolizumab plus axitinib for metastatic papillary and chromophobe kidney cancer
Non-clear cell kidney cancer is a group of different subtypes [...]
Non-clear cell kidney cancer is a group of different subtypes [...]
In this study, real world data is used to compare [...]
A recent paper published in The Oncologist has shown that [...]
At the 2023 Society of Urologic Oncology (SUO) Annual Meeting, [...]
Over 400,000 people are diagnosed with kidney cancer globally each [...]
When cancer is diagnosed early, it is easier to treat [...]
This review of the literature looked at how common psychological [...]
This study looked at whether high or low body mass [...]
The National Institute for Health and Care Excellence (NICE) has [...]
Stereotactic ablative body radiotherapy (SABR) uses an intense beam of [...]